Human Genome Epidemiology Literature Finder
Records 1 - 2 (of 2 Records) |
Query Trace: Peripheral Arterial Disease and CYP2C19[original query] |
---|
Patients carrying CYP2C19 loss of function alleles have a reduced response to clopidogrel therapy and a greater risk of in-stent restenosis after endovascular treatment of lower extremity peripheral arterial disease. Journal of vascular surgery 2014 Oct 60 (4): 993-1001. Guo Baolei, Tan Qiwen, Guo Daqiao, Shi Zhenyu, Zhang Chunyan, Guo W |
CYP2C19 genotype-guided antithrombotic treatment versus conventional clopidogrel therapy in peripheral arterial disease: study design of a randomized controlled trial (GENPAD). American heart journal 2022 8 254 141-148. Kranendonk J, Willems L H, Vijver-Coppen Rj van der, Coenen M, Adang E, Donders R, Zeebregts C J, Deneer Vhm, Reijnen Mmpj, Kramers C, Warlé M |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: